Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH)

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Yoneda, Masato ^a   Uchiyama, Takashi ^a   Kato, Shingo ^a   Endo, Hiroki ^a   Fujita, Koji ^a   Yoneda, Kyoko ^a   Mawatari, Hironori ^a   Iida, Hiroshi ^a   Takahashi, Hirokazu ^a   Kirikoshi, Hiroyuki ^a   Inamori, Masahiko ^a   Nozaki, Yuichi ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Maeyama, Shiro ^b   Sagara, Mina ^c   Aburatani, Hiroyuki ^d   Kodama, Tatsuhiko ^d   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kitakashiwa Rehabilitation Hospital   (Japan)

^c Perseus Proteomics   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYALURONIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTRAXIN 3; TRIACYLGLYCEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; SERUM AMYLOID P;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INTRAABDOMINAL FAT; JAPANESE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; PREDICTION; ROC CURVE; SUBCUTANEOUS FAT; THROMBOCYTE COUNT; AGED; BLOOD; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; HOSPITALIZATION; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATTY LIVER; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; SERUM AMYLOID P-COMPONENT; SEVERITY OF ILLNESS INDEX;

EID: 58249104011     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-53     Document Type: Article

References (49)

1. Angulo P Nonalcoholic fatty liver disease N Engl J Med 2002, 18:1221-31
2. Farrell GC Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003, 18:124-38 12542595
3. Diehl AM Goodman Z Ishak KG Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury Gastroenterology 1988, 95:1056-62 3410220
4. Ludwig J Viggiano TR McGill DB Oh BJ Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 1980, 55:434-8 7382552
5. Angulo P Keach JC Batts KP Lindor KD Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 1999, 30:1356-62 10573511
6. Cadranel JF Good clinical practice guidelines for fine needle aspiration biopsy of the liver: Past, present and future Gastroenterol Clin Biol 2002, 26:823-824 12434092
7. Sakugawa H Nakayoshi T Kobashigawa K Yamashiro T Maeshiro T Miyagi S Shiroma J Toyama A Nakayoshi T Kinjo F Saito A Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease World J Gastroenterol 2005, 11:255-9 15633226
8. Ratziu V Giral P Charlotte F Bruckert E Thibault V Theodorou I Khalil L Turpin G Opolon P Poynard T Liver fibrosis in overweight patients Gastroenterology 2000, 118:1117-23 10833486
9. Shimada M Hashimoto E Kaneda H Noguchi S Hayashi N Nonalcoholic steatohepatitis: Risk factors for liver fibrosis Hepatol Res 2002, 24:429-438 12479942
10. Yoneda M Mawatari H Fujita K Iida H Yonemitsu K Kato S Takahashi H Kirikoshi H Inamori M Nozaki Y Abe Y Kubota K Saito S Iwasaki T Terauchi Y Togo S Maeyama S Nakajima A High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH J Gastroenterol 2007, 42:573-82 17653654
11. Pepys MB Baltz ML Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein Adv Immunol 1983, 34:141-212 6356809
12. Garlanda C Bottazzi B Bastone A Mantovani A Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility Annu Rev Immunol 2005, 23:337-66 15771574
13. Doni A Michela M Bottazzi B Peri G Valentino S Polentarutti N Garlanda C Mantovani A Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: Stimulation by IL-10 and inhibition by IFN-gamma J Leukoc Biol 2006, 79:797-802 16461742
14. Breviario F d'Aniello EM Golay J Peri G Bottazzi B Bairoch A Saccone S Marzella R Predazzi V Rocchi M Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component J Biol Chem 1992, 267:22190-7 1429570
15. Lee GW Lee TH Vilcek J TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins J Immunol 1993, 150:1804-12 7679696
16. Introna M Alles VV Castellano M Picardi G De Gioia L Bottazzai B Peri G Breviario F Salmona M De Gregorio L Dragani TA Srinivasan N Blundell TL Hamilton TA Mantovani A Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites Blood 1996, 87:1862-72 8634434
17. Alles VV Bottazzi B Peri G Golay J Introna M Mantovani A Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes Blood 1994, 84:3483-93 7949102
18. Abderrahim-Ferkoune A Bezy O Chiellini C Maffei M Grimaldi P Bonino F Moustaid-Moussa N Pasqualini F Mantovani A Ailhaud G Amri EZ Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells J Lipid Res 2003, 44:994-1000 12611905
19. Klouche M Peri G Knabbe C Eckstein HH Schmid FX Schmitz G Mantovani A Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells Atherosclerosis 2004, 175:221-8 15262177
20. Fazzini F Peri G Doni A Dell'Antonio G Dal Cin E Bozzolo E D'Auria F Praderio L Ciboddo G Sabbadini MG Manfredi AA Mantovani A Querini PR PTX3 in small-vessel vasculitides: An independent indicator of disease activity produced at sites of inflammation Arthritis Rheum 2001, 44:2841-50 11762945
21. Peri G Introna M Corradi D Iacuitti G Signorini S Avanzini F Pizzetti F Maggioni AP Moccetti T Metra M Cas LD Ghezzi P Sipe JD Re G Olivetti G Mantovani A Latini R PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans Circulation 2000, 102:636-41 10931803
22. Latini R Maggioni AP Peri G Gonzini L Lucci D Mocarelli P Vago L Pasqualini F Signorini S Soldateschi D Tarli L Schweiger C Fresco C Cecere R Tognoni G Mantovani A Lipid Assessment Trial Italian Network (LATIN) Investigators Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction Circulation 2004, 110:2349-54 15477419
23. Muller B Peri G Doni A Torri V Landmann R Bottazzi B Mantovani A Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients Crit Care Med 2001, 29:1404-7 11445697
24. Sanyal AJ AGA technical review on nonalcoholic fatty liver disease Gastroenterology 2002, 123:1705-25 12404245
25. Suzuki S Takeishi Y Niizeki T Koyama Y Kitahara T Sasaki T Sagara M Kubota I Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure Am Heart J 2008, 155:75-81 18082493
26. Kravitz MS Shoenfeld Y Autoimmunity to protective molecules: Is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic disease? Nat Clin Pract Rheumatol 2006, 2(9):481-490 16951703
27. Morikawa S Takabe W Mataki C Wada Y Izumi A Saito Y Hamakubo T Kodama T Global analysis of RNA expression profile in human vascular cells treated with statins J Atheroscler Thromb 2004, 11:62-72 15153665
28. Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 412 9 3899825
29. Yoshizumi T Nakamura T Yamane M Islam AH Menju M Yamasaki K Arai T Kotani K Funahashi T Yamashita S Matsuzawa Y Abdominal fat: Standardized technique for measurement at CT Radiology 1999, 211:283-286 10189485
30. Teli MR James OF Burt AD Bennett MK Day CP The natural history of nonalcoholic fatty liver: A follow-up study Hepatology 1995, 22:1714-9 7489979
31. Matteoni CA Younossi ZM Gramlich T Boparai N Liu YC McCullough AJ Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity Gastroenterology 1999, 116:1413-9 10348825
32. Hui JM Kench JG Chitturi S Sud A Farrell GC Byth K Hall P Khan M George J Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C Hepatology 2003, 38:420-7 12883486
33. Brunt EM Nonalcoholic steatohepatitis: Definition and pathology Semin Liver Dis 2001, 21:3-16 11296695
34. Sanyal AJ Treatment of non-alcoholic fatty liver disease J Gastroenterol Hepatol 2002, 17(Suppl 3):S385-S388 12472968
35. Park SH Kim BI Yun JW Kim JW Park DI Cho YK Sung IK Park CY Sohn CI Jeon WK Kim H Rhee EJ Lee WY Kim SW Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men J Gastroenterol Hepatol 2004, 19:694-8 15151626
36. Park SH Jeon WK Kim SH Kim HJ Park DI Cho YK Sung IK Sohn CI Keum DK Kim BI Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults J Gastroenterol Hepatol 2006, 21:138-43 16706825
37. Hanley AJ Williams K Festa A Wagenknecht LE D'Agostino RB Jr Haffner SM Liver markers and development of the metabolic syndrome: The insulin resistance atherosclerosis study Diabetes 2005, 54:3140-7 16249437
38. Mantovani A Garlanda C Bottazzi B Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity Vaccine 2003, 21(Suppl 2):S43-7 12763682
39. Garlanda C Bottazzi B Bastone A Mantovani A Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility Annu Rev Immunol 2005, 23:337-66 15771574
40. Crespo J Cayón A Fernández-Gil P Hernández-Guerra M Mayorga M Domínguez-Díez A Fernández-Escalante JC Pons-Romero F Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 2001, 34:1158-63 11732005
41. Nozaki Y Saibara T Nemoto Y Ono M Akisawa N Iwasaki S Hayashi Y Hiroi M Enzan H Onishi S Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis Alcohol Clin Exp Res 2004, 28(8 Suppl) Proceedings 106S-110S 15318095
42. Kirsch R Clarkson V Verdonk RC Marais AD Shephard EG Ryffel B de la M Hall P Rodent nutritional model of steatohepatitis: Effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency J Gastroenterol Hepatol 2006, 21:174-82 16706830
43. Patel DA Srinivasan SR Xu JH Li S Chen W Berenson GS Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: The Bogalusa Heart Study Metabolism 2006, 55:699-705 16713426
44. Ridker PM Buring JE Cook NR Rifai N C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14719 initially healthy American women Circulation 2003, 107:391-7 12551861
45. Kang H Greenson JK Omo JT Chao C Peterman D Anderson L Foess-Wood L Sherbondy MA Conjeevaram HS Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD Am J Gastroenterol 2006, 101:2247-53 17032189
46. Inoue K Sugiyama A Reid PC Ito Y Miyauchi K Mukai S Sagara M Miyamoto K Satoh H Kohno I Kurata T Ota H Mantovani A Hamakubo T Daida H Kodama T Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris Arterioscler Thromb Vasc Biol 2007, 27:161-7 17095712
47. Rovere P Peri G Fazzini F Bottazzi B Doni A Bondanza A Zimmermann VS Garlanda C Fascio U Sabbadini MG Rugarli C Mantovani A Manfredi AA The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells Blood 2000, 96:4300-6 11110705
48. Souza DG Soares AC Pinho V Torloni H Reis LF Teixeira MM Dias AA Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury Am J Pathol 2002, 160:1755-65 1850862 12000727
49. Kotooka N Inoue T Fujimatsu D Morooka T Hashimoto S Hikichi Y Uchida T Sugiyama A Node K Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening Atherosclerosis 2008, 197:368-74 17640648